By using our site, you acknowledge that you have read and understand our Privacy and Cookie Policy.
All trademarks listed on this website are the property of their respective owners. All rights reserved.
Copyright © 2026 DataArt

As artificial intelligence transforms healthcare, more companies are adding AI to medical devices to enhance diagnostics, personalize treatments, and increase patient engagement. With AI playing a larger role in clinical decision-making, it is now essential for businesses to prioritize validation and regulatory compliance when integrating AI into their products.

DataArt recently hosted a webinar to explore the validation of AI-enabled medical devices for the European market and provide practical guidance on aligning with MDR, GDPR, and the EU AI Act.
The panel of experts moderated by Varvara Bogdanova, Innovations Manager, HCLS, DataArt, included:
This article summarizes the key insights from the webinar.
AI validation is essential for several reasons that significantly impact patient safety, technology reliability, and business success.
Clinically, the influence of AI on medical decisions is profound. Errors in AI algorithms can lead to incorrect diagnoses or treatment recommendations, directly affecting patient health.
Technically, as AI constantly evolves, it must be regularly tested for various parameters, such as robustness and bias real-world performance. This way, we understand what to expect from AI devices and what can potentially go wrong.
From a business perspective, a lack of proper validation can lead to product rejections, recalls, and a significant loss of consumer trust. Recent reports indicate a correlation between the introduction of AI devices to the market and recalls, particularly highlighting those that did not undergo thorough validation in the first place.
The development and validation of AI-based medical devices come with a number of complex challenges.
AI in healthcare is advancing rapidly, but regulatory guidance often lags behind, creating uncertainty for manufacturers. Standards differ across regions setting distinct and sometimes conflicting requirements.
High-quality, representative datasets are essential for clinical-grade AI, as poor data can lead to bias or unreliable outcomes. Companies must demonstrate lawful processing, clinical relevance, and strict governance of data throughout its lifecycle. Regulatory authorities require validation results and documentation to always reflect the current AI system version, tracking changes as models are retrained or updated.
Building AI-powered medical devices requires robust lifecycle management, including data acquisition, preprocessing, training, rigorous validation with diverse datasets, secure deployment, and post-market monitoring.
I believe that many organizations underestimate how operationally demanding it is to maintain the full AI lifecycle in compliance. There are several very big groups of requirements for medical software development, AI, cybersecurity, as well as data governance and privacy.
Cloud services can help teams develop, validate, and monitor AI-based medical devices more efficiently in a number of areas.
One of the main challenges in regulated industries is the burden of manual documentation and reporting. Cloud services offer built-in automation for many quality controls and compliance checks, greatly reducing the need for manual paperwork.
Regulatory requirements for testing are evolving with the types of AI being used. For deterministic systems, automated tests were often sufficient. For non-deterministic systems, such as large language models, cloud platforms enable new forms of testing, like incorporating “human-in-the-loop” validation or using one model to judge the outputs of another (an LLM as a judge). Automated testing frameworks available in the cloud allow teams to efficiently adapt to regulatory expectations.
AI models and the data they are trained on change rapidly. Cloud services enable teams to embrace change through robust automation of version control, retraining, and model validation processes. Features such as predetermined change control plans, recommended by regulators, become feasible and manageable in the cloud.
Some businesses try to control change by locking their AI models, but with LLMs continually evolving and real-world data constantly shifting, this approach is risky. I recommend that companies embrace change and proactively build it into their planning. This requires experts who understand both technology and compliance, and they are hard to find. That’s why I’m really glad we have partners like DataArt.
A recurring question in AI validation for medical devices is: what qualifies as convincing evidence that an AI system is safe, effective, and trustworthy. The answer is evolving and context-dependent.
If someone asks how much data is enough to validate AI, the honest answer is there’s no fixed number. And, more importantly, regulators don’t expect one, instead they anticipate a justified, risk-based rationale.
AI validation typically starts with a few hundred well-curated samples to catch major failures, but as coverage expands to clinical language, edge cases, and patient variability, thousands of samples may be needed. The exact amount of data depends on the complexity, intended clinical use, and risk profile of the AI system. Metrics like accuracy and recall are statistical estimates, where a tighter confidence interval often requires more data. Reliable validation is not just technical, it also needs expert review, careful annotation, and sometimes AI-assisted evaluation with human oversight.
From a regulatory point of view, evidence must be comprehensive, up-to-date, and reflect the current state of the system. This requires updates after model retraining, data changes, or new risk findings. Documentation, risk management, and performance monitoring should align with overlapping frameworks like MDR, GDPR, and the EU AI Act. Ultimately, AI validation is an ongoing process: regular updates help ensure medical devices remain safe, effective, and compliant throughout their lifecycle.
The partnership between DataArt and Amazon Web Services provides businesses with a powerful framework for validating AI in medical devices.
Amazon Web Services offer cloud-based tools such as Bedrock and SageMaker to automate model evaluation, implement compliance guardrails, and enable continuous monitoring for bias, toxicity, robustness, and more. These solutions help organizations meet regulatory expectations for risk mitigation and evidence generation.
DataArt brings deep regulatory and technical expertise, helping integrate these tools into workflows designed for MDR, GDPR, and EU AI Act compliance. This collaboration simplifies the process of creating audit-ready documentation, aligning automated validation with international standards for medical software development.
Together, DataArt and Amazon Web Services empower organizations to deliver safer, more effective, and compliant AI-powered medical devices.
Validating AI in medical devices requires risk-based planning, robust testing, ongoing monitoring, and alignment with complex regulations such as MDR, GDPR, and the EU AI Act. DataArt and AWS together offer a powerful combination of cloud technologies and expert regulatory guidance, enabling organizations to validate, monitor, and continually improve their AI-powered medical devices with confidence.
You can watch the full webinar and get more insights on AI validation digital products here:
Contact us if you need help with designing, validating, and deploying AI-powered medical devices that meet MDR, GDPR, and the EU AI Act requirements.
Subscribe now to get a monthly recap of our biggest news delivered to your inbox!
By using our site, you acknowledge that you have read and understand our Privacy and Cookie Policy.
All trademarks listed on this website are the property of their respective owners. All rights reserved.
Copyright © 2026 DataArt
By clicking 'Accept All Cookies', you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. More information

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
All Consent Allowed